Patient Safety

Supporting safer use of medicines and healthcare products.

ADR Monitoring

Identification and documentation of adverse drug reactions.

ADR Reporting

Facilitating appropriate reporting of suspected ADRs.

Safety Surveillance

Supporting continuous monitoring of medicine-related safety.

Monitoring Medicines for Safer Patient Care

The Pharmacovigilance Committee supports the identification, documentation and reporting of suspected adverse drug reactions arising during patient care.

The Committee promotes awareness among healthcare professionals regarding medicine safety and appropriate ADR reporting practices under the applicable pharmacovigilance framework.

Promoting ADR awareness
Monitoring suspected adverse reactions
Supporting appropriate ADR documentation
Strengthening medicine safety practices
Medicine Safety Monitor • Report • Protect

Adverse Drug Reaction Reporting

Suspected adverse drug reactions should be identified, documented and reported through the appropriate institutional and pharmacovigilance channels.

01

Identify

Recognise and assess a suspected adverse reaction during patient care.

02

Document

Record relevant clinical and medicine-related information required for evaluation.

03

Report

Submit the suspected ADR through the designated reporting mechanism.

04

Improve Safety

Pharmacovigilance information contributes to safer medicine-use practices.

Pharmacovigilance Committee Members

Designated members responsible for supporting pharmacovigilance activities and medicine safety initiatives.

Reconstituted on 10/03/2026  |  Ref. No. LBKMCH/Pharma/28/2026

PV Committee
# Member Department Role Contact
01
Dr. Jyotishman Mukhopadhyay Honorable Dean, LBKMCH
Dean Office Chairperson / Respected Dean & Patron
02
Dr. Md. Amir Alam Professor, Pharmacology
Pharmacology Nodal Officer
03
Dr. Krishna Pandey Associate Professor, Pharmacology
Pharmacology Member Secretary
04
Dr. Varun Kumar Thakur Professor, ENT
ENT Member
05
Dr. Ram Ranjan Singh Professor, Biochemistry
Biochemistry Member
06
Dr. Randhir Kumar Professor, Community Medicine
Community Medicine Member
07
Dr. Surbhi Sindhu Associate Professor, Microbiology
Microbiology Member
08
Dr. Brajesh Kumar Singh Associate Professor, Gen. Medicine
General Medicine Member
09
Dr. Niyaz Alam Professor, Principal, Pharmacy College
Pharmacy College Member
10
Ms. Asha Marry Nursing Superintendent
Nursing Superintendent Member

Official Committee Notice

Download the official notification regarding the reconstitution of the Institutional Pharmacovigilance Committee, LBKMCH, approved by Dr. Jyotishman Mukhopadhyay, Dean LBKMCH.

Date: 10/03/2026 Ref. No: LBKMCH/Pharma/28/2026 LBKMCH, Saharsa PDF
Download Notice Letter

Pharmacovigilance at a Glance

Medicine Safety

Supporting safe and rational use of medicines in clinical practice.

Healthcare Professionals

Encouraging doctors, nurses and other professionals to remain vigilant about suspected ADRs.

Safety Information

Promoting accurate documentation of relevant medicine safety information.

Institutional Safety

Strengthening pharmacovigilance practices within the healthcare institution.

MEDICINE SAFETY

Suspected Adverse Drug Reaction?

Healthcare professionals should follow the institutional process for documenting and reporting suspected ADRs.

Contact Committee